Study Title and Description
Vaginal clindamycin in preventing preterm birth and peripartal infections in asymptomatic women with bacterial vaginosis: a randomized, controlled trial.
Key Questions Addressed
|4||Does treatment of bacterial vaginosis during pregnancy reduce preterm delivery and related morbidity and mortality? a) Does the effect of treatment vary by baseline risk (e.g., low- vs. high-risk) for preterm delivery? b) Does the effect of treatment vary by race/ethnicity? c) Does the effect of treatment vary by maternal age? d) Does the effect of treatment vary by gestational age? e) Does the effect of treatment vary by other risks for preterm delivery (e.g., coinfection with STIs, HIV status)?|
|5||What are the harms of treatment of bacterial vaginosis in pregnant adolescents and women? a) What are harms to pregnant adolescents and women? b) What are harms to the fetus or newborn?|
Primary Publication Information
|Title||Vaginal clindamycin in preventing preterm birth and peripartal infections in asymptomatic women with bacterial vaginosis: a randomized, controlled trial.|
|Author||Kekki M., Kurki T., Pelkonen J., Kurkinen-Räty M., Cacciatore B., Paavonen J.|
|Country||Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland. firstname.lastname@example.org|
Pubmed ID: 11339909
Secondary Publication Information
|A randomised controlled trial of vaginal clindamycin for early pregnancy bacterial vaginosis.||Kurkinen-Räty M., Vuopala S., Koskela M., Kekki M., Kurki T., Paavonen J., Jouppila P.||Department of Obstetrics and Gynaecology, Oulu University, Finland.||2000|
Extraction Form: Study Data for this published project can be accessed from the SRDR Published Projects page, under the link in the Study Notes section of this project
Results & Comparisons
No Results found.